Cargando…

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is one of the most lethal cancers. Although complete surgical resection is the only curative treatment for pancreatic cancer, a late diagnosis is common and makes surgical treatment infeasible. Therefore, most patients receive chemotherapy to reduce the tumor burden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hai, Liu, Bin, Liu, Dongxue, Yang, Zhirong, Zhang, Shuman, Xu, Pengyan, Xing, Yuming, Kutschick, Isabella, Pfeffer, Susanne, Britzen-Laurent, Nathalie, Grützmann, Robert, Pilarsky, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264918/ https://www.ncbi.nlm.nih.gov/pubmed/35804923 http://dx.doi.org/10.3390/cancers14133152

Ejemplares similares

Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator
por: He, Hang, et al.
Publicado: (2022)

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2022)

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022)

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023)

CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
por: Zeng, Siyuan, et al.
Publicado: (2022)

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway
por: Stukas, Darius, et al.
Publicado: (2023)

CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines
por: Lentsch, Eva, et al.
Publicado: (2019)

dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study
por: Xiong, Junjie, et al.
Publicado: (2016)

The Role of Deoxycytidine Kinase (dCK) in Radiation-Induced Cell Death
por: Zhong, Rui, et al.
Publicado: (2016)

DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines
por: Zhao, Ya-Hui, et al.
Publicado: (2022)

Assistententag des Jungen Forums der DGMKG – DCK 2021
por: Thiem, Daniel
Publicado: (2021)

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
por: Patel, Girijesh Kumar, et al.
Publicado: (2017)

DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer
por: Hu, Shu Fang, et al.
Publicado: (2020)

TFIP11, CCNL1 and EWSR1 Protein-protein Interactions, and Their Nuclear Localization
por: Tannukit, Sissada, et al.
Publicado: (2008)

Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight
por: Freathy, Rachel M, et al.
Publicado: (2010)

The Interplay of Variants Near LEKR and CCNL1 and Social Stress in Relation to Birth Size
por: Ali Khan, Anokhi, et al.
Publicado: (2012)

Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML
por: Kurata, Morito, et al.
Publicado: (2016)

dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer
por: Hu, Qiangsheng, et al.
Publicado: (2018)

CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019)

Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2
por: Liu, HaiTao, et al.
Publicado: (2016)

DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study
por: Woo, Sang Myung, et al.
Publicado: (2017)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1
por: Zeng, Xing, et al.
Publicado: (2022)

Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma
por: Muller, D, et al.
Publicado: (2006)

A consistent and corrected nighttime light dataset (CCNL 1992–2013) from DMSP-OLS data
por: Zhao, Chenchen, et al.
Publicado: (2022)

Overexpression of miR-199b-5p inhibits Ewing's sarcoma cell lines by targeting CCNL1
por: LI, WEIHUA, et al.
Publicado: (2015)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer
por: Liu, Bin, et al.
Publicado: (2018)

Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas
por: Rückert, Felix, et al.
Publicado: (2012)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

The Small Yeast GTPase Rho5 and Its Dimeric GEF Dck1/Lmo1 Respond to Glucose Starvation
por: Schmitz, Hans-Peter, et al.
Publicado: (2018)

Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression
por: Buocikova, Verona, et al.
Publicado: (2022)

Absence of Birth-Weight Lowering Effect of ADCY5 and Near CCNL, but Association of Impaired Glucose-Insulin Homeostasis with ADCY5 in Asian Indians
por: Vasan, Senthil K., et al.
Publicado: (2011)

Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases
por: Britzen-Laurent, Nathalie, et al.
Publicado: (2023)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

The Role of Exosomes in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2019)

Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer
por: Elebro, Jacob, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_98kd9voaks3aq294r7u9b0dve6